CAPR Competitors & Alternatives
Compare Capricor Therapeutics Inc with similar stocks in the same industry
Biotechnology
CAPR
Main Stock$20.61
Tradestie Score
44
Market Cap
$357.51M
Revenue Growth
-0.1%
Analyst Upside
+160.1%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.16
|
$1.29B | 119.1 | 61 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.46
|
$1.29B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.14
|
$1.29B | - | 52 | Compare |
|
ZYME
Zymeworks Inc.
|
$24.94
|
$1.28B | - | 54 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$5.77
|
$1.27B | - | 55 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$43.95
|
$1.26B | - | 61 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$4.97
|
$1.22B | - | 63 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$5.17
|
$1.18B | - | 59 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$50.87
|
$1.17B | - | 63 | Compare |
More CAPR Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry